A series of 1-(4-indolyloxy)-3-(4-hydroxy-4-naphthylpiperidin-1-yl)propanes are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1A receptor, yet lack mutagenic potential as measured by assays of chromosomal aberration. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.
一系列 1-(4-
吲哚氧基)-3-(
4-羟基-4-
萘基
哌啶-1-基)
丙烷是治疗与 5-羟
色胺再摄取和 5-羟
色胺 1A 受体有关或受其影响的疾病的有效药物,但通过染色体畸变测定,缺乏诱变潜力。这些化合物尤其适用于缓解
尼古丁和烟草戒断症状,以及治疗抑郁症和其他使用
血清素再摄取
抑制剂的疾病。